Effect of Opioid Use and Fibromyalgia on Steroid Metabolome and Adrenal Function

Overview

Información sobre este estudio

The purpose of this study is to determine the abnormalities in urine steroid profiling and association to the daily opioid dose in patients treated with opioids as compared to the existent cohort of healthy controls, and to identify the steroid signature associated with low quality of life, including physical and mental health.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Cross sectional study of prospectively enrolled 150 patients who will be enrolled from the pain clinic and endocrine clinic based on the following criteria:
    • Age 18 years and above;
    • Current opioid use of at least 20 MME per day, for at least 3 months;
    • Ability to provide informed consent;
    • Willingness to participate in study procedures;
    • Absence of known or suspected adrenal insufficiency of any other cause ( pituitary surgery, megace, etc.) or glucocorticoid exposure;
    • Pregnant women will be excluded on the basis that the steroid profile results could be skewed because of hormonal cause. Women of childbearing potential will be asked if they are pregnant and, if so, will then be excluded from participation.
  • Assessment – one-time assessment (cross-sectional study) to include the following:
    • Medical record review:
      • Type, dose and duration of opioid use, other medication use and steroid use;
      • Demographic information;
      • Comorbidities;
      • Type of pain/indications for opioid therapy.
    • Health interview:
      • Confirmation of duration and dose of opioids;
      • Review of medications and comorbidities;
      • Review of exogenous steroid use;
      • Smoking history;
      • AddiQOL survey;
      • SF36 survey.
  • Physical assessment:
    • 6 minute walk test.
  • Biomaterial collection and measurements:
    • Morning ACTH, cortisol and DHEAS measurements (clinical measurement);
    • 24 h urine collection for cortisol (clinical measurement) and steroid profiling assessment (research test).

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Irina Bancos, M.D.

Cerrado para la inscripción

Contact information:

Vanessa Fell

(507) 266-6068

Fell.Vanessa@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20457706

Mayo Clinic Footer